Gujarat’s First Hospital to Introduce 24×7 AI-Powered Remote Monitoring for High-Risk Patients, Enabling Real-Time Clinical Intervention Through Continuous Biosensor-Based Surveillance
Ahmedabad, 7 August 2026
Marengo CIMS Hospitals has become Gujarat’s first hospital to introduce a 24×7 AI-powered remote patient monitoring ecosystem for high-risk patients, enabling continuous monitoring not only inside the hospital but also after discharge at home and even while patients are travelling. The advanced technology is transforming patient care by identifying life-threatening health deterioration before it turns into a medical emergency.
The intelligent monitoring platform at Marengo CIMS Hospitals uses wearable AI-enabled biosensor technology to continuously track vital parameters, including heart rate, blood pressure, respiratory rate, oxygen saturation, and other critical physiological indicators in real time. If the system detects any abnormality or increasing clinical risk, it instantly sends alerts simultaneously to the patient’s smartphone, the treating doctor, and Marengo CIMS Hospitals’ dedicated 24×7 Central Monitoring Command Centre, allowing immediate medical intervention.
The AI platform creates a connected care ecosystem that follows the patient throughout the healthcare journey—from ambulance and emergency care to the ICU, hospital wards, home recovery, and beyond. By continuously analysing patient data and identifying subtle physiological changes, the system provides doctors with early warning scores, explainable risk insights, and real-time clinical summaries, enabling faster and more informed treatment decisions.
Speaking on this breakthrough, Dr. Dhiren Shah, Director, CVTS & Heart Transplant Programme, Marengo CIMS Hospital, said:
“Marengo CIMS Hospitals has been using this AI-enabled biosensor technology for more than two and a half years for patients at high risk of cardiac and other life-threatening conditions. During this period, the hospital has monitored over 6,551 patients, successfully prevented 836 cases of patient deterioration, avoided 115 Code Blue emergencies, prevented 81 ICU transfers, and facilitated three successful life-saving CPR interventions, demonstrating the significant impact of AI-assisted continuous monitoring on patient outcomes.”
The technology is especially beneficial for patients with heart failure, weakened heart function, high-risk cardiovascular disease, stroke risk, asthma, and other chronic critical illnesses. Unlike conventional monitoring, which is limited to hospital stays, the AI platform enables doctors to remotely monitor patients even after discharge, ensuring continuity of care while allowing patients to recover safely in the comfort of their homes.
Marengo CIMS Hospitals has also established a dedicated 24×7 AI Monitoring Command Centre, where trained clinical teams continuously review patient data, verify alerts, and coordinate with treating doctors whenever intervention is required. This proactive approach helps clinicians identify deterioration well before symptoms become clinically evident, reducing emergency admissions and improving patient safety.
Mayur Dave, Facility Director, Marengo CIMS Hospital, added:
“Most serious cardiac emergencies do not occur suddenly. The human body gives subtle physiological signals hours or even days before a critical event such as heart failure. Our AI-powered monitoring ecosystem enables us to identify these warning signs at the earliest stage, allowing doctors to intervene before the patient’s condition becomes critical. Over the past two and a half years, this technology has helped us prevent 115 Code Blue emergencies while continuously monitoring thousands of high-risk patients. This is not just remote monitoring—it is predictive, preventive, and personalised healthcare powered by artificial intelligence. We believe this technology will redefine how critical care is delivered in Gujarat.”
Dr. Raajiv Singhal, Founding Member, Managing Director & CEO, Marengo Asia Healthcare, said:
“The AI-powered platform also supports structured hospital workflows through continuous clinical monitoring, intelligent risk stratification, AI-assisted documentation, and coordinated escalation protocols, ensuring that healthcare teams receive the right information at the right time. By preserving patient context across every stage of care, Marengo CIMS Hospitals is enabling earlier clinical intervention, reducing avoidable complications, lowering treatment costs, reducing ICU and overall hospital stays, and improving recovery outcomes.”
About Lifesigns
Lifesigns is an AI-powered patient monitoring and clinical intelligence company that helps hospitals identify patient deterioration earlier and prioritise patients based on clinical risk. Its technology combines continuous remote monitoring, predictive risk stratification, explainable clinical insights, and automated documentation across the full patient journey—from first contact through hospital treatment, critical care, procedures, and recovery at home. By analysing live vital signs alongside available laboratory results, clinical notes, reports, and patient history, Lifesigns gives healthcare teams a clearer and more comprehensive view of each patient to support timely clinical decision-making.
With the adoption of this advanced AI ecosystem, Marengo CIMS Hospitals has set a new benchmark in digital healthcare and become Gujarat’s first hospital to offer 24×7 AI-driven continuous patient monitoring, reaffirming its commitment to innovation, clinical excellence, and world-class patient care.
